Concepedia

Shun Xu

SX

32

Publications

1.6K

Citations

18

H-Index

2009

Active since

Affiliations

First Hospital of China Medical University(Current)

China Medical University

Sun Yat-sen University

Fudan University

Sichuan University

Shun Xu is an author at First Hospital of China Medical University specializing in medicine, virology, and oncology.

ORCID

Top concepts

Publications per year

2009–2023

32

Publications

32

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 520 citations

, , +8

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · Journal of Clinical Oncology · 2020 · 261 citations · Full text

Marek's Disease Virus Type 1 MicroRNA miR-M3 Suppresses Cisplatin-Induced Apoptosis by Targeting SMAD2 of the Transforming Growth Factor Beta Signal Pathway

Shun Xu, Chunyi Xue, Jianping Li et al. · Journal of Virology · 2010 · 82 citations · Full text

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

Junjie Xi, Wen‐Zhao Zhong, Weimin Mao et al. · Journal of Thoracic Oncology · 2018 · 72 citations

, , +9

Cell‐Free Extracts from Human Fat Tissue with a Hyaluronan‐Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization

Guangyu Xu, Shun Xu, Yu‐Xuan Zhang et al. · Small · 2022 · 72 citations

, , +23

Rows per page

1–5 of 32